华厦眼科
(301267)
| 流通市值：85.89亿 | | | 总市值：219.41亿 |
| 流通股本：3.29亿 | | | 总股本：8.40亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 978,184,584.19 | 4,013,164,370.86 | 3,102,868,888.04 | 1,993,689,033.8 |
| 营业收入 | 978,184,584.19 | 4,013,164,370.86 | 3,102,868,888.04 | 1,993,689,033.8 |
| 二、营业总成本 | 764,366,715.1 | 3,144,214,269.48 | 2,353,594,879.58 | 1,507,952,028.5 |
| 营业成本 | 499,203,391.03 | 2,045,424,205.77 | 1,532,291,121.22 | 990,865,292.28 |
| 税金及附加 | 3,362,384.8 | 13,952,387.39 | 10,484,886.36 | 7,307,906.57 |
| 销售费用 | 124,981,288.32 | 532,831,672.1 | 398,169,075.71 | 245,331,075.24 |
| 管理费用 | 113,855,680.53 | 462,313,896.04 | 334,330,260.58 | 215,423,871.11 |
| 研发费用 | 17,303,375.36 | 69,684,270.32 | 62,346,901.73 | 39,863,720.62 |
| 财务费用 | 5,660,595.06 | 20,007,837.86 | 15,972,633.98 | 9,160,162.68 |
| 其中:利息费用 | 10,297,005.38 | 38,035,901.79 | 29,901,489.66 | 20,140,046.72 |
| 其中:利息收入 | 6,063,414.07 | 23,524,618.02 | 18,146,116.95 | 13,544,188.97 |
| 加:公允价值变动收益 | 20,521,929.11 | 11,020,662.09 | 11,686,645.54 | 8,537,714.37 |
| 加:投资收益 | 2,242,493.47 | 76,437,566.9 | 47,532,617.8 | 31,220,054.26 |
| 资产处置收益 | 413,098.83 | 11,277,025.2 | 967,995.49 | 884,569.08 |
| 资产减值损失(新) | -4,790.7 | -5,552,388.53 | -161,005.31 | -13,233.66 |
| 信用减值损失(新) | -5,263,470.7 | -11,837,203.13 | -11,557,806.09 | -9,393,474.16 |
| 其他收益 | 2,141,270.98 | 23,101,355.05 | 11,521,144.06 | 5,154,904.19 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 233,868,400.08 | 973,397,118.96 | 809,263,599.95 | 522,127,539.38 |
| 加:营业外收入 | 770,176.15 | 1,363,353.5 | 1,113,911.61 | 823,927.94 |
| 减:营业外支出 | 24,694,813.72 | 120,447,605.34 | 90,871,293.69 | 56,884,110.97 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 209,943,762.51 | 854,312,867.12 | 719,506,217.87 | 466,067,356.35 |
| 减:所得税费用 | 45,155,712.72 | 176,892,624.93 | 150,141,726.69 | 100,876,777.42 |
| 六、净利润 | 164,788,049.79 | 677,420,242.19 | 569,364,491.18 | 365,190,578.93 |
| 持续经营净利润 | 164,788,049.79 | 677,420,242.19 | 569,364,491.18 | 365,190,578.93 |
| 归属于母公司股东的净利润 | 155,917,808.87 | 665,932,077.37 | 557,387,738.64 | 354,706,803.55 |
| 少数股东损益 | 8,870,240.92 | 11,488,164.82 | 11,976,752.54 | 10,483,775.38 |
| (一)基本每股收益 | 0.19 | 0.79 | 0.66 | 0.63 |
| (二)稀释每股收益 | 0.19 | 0.79 | 0.66 | 0.63 |
| 八、其他综合收益 | -143,862.05 | 31,610,016.49 | 20,384,362.87 | -248,410.79 |
| 归属于母公司股东的其他综合收益 | -143,862.05 | 31,610,016.49 | 20,384,362.87 | -248,410.79 |
| 九、综合收益总额 | 164,644,187.74 | 709,030,258.68 | 589,748,854.05 | 364,942,168.14 |
| 归属于母公司股东的综合收益总额 | 155,773,946.82 | 697,542,093.86 | 577,772,101.51 | 354,458,392.76 |
| 归属于少数股东的综合收益总额 | 8,870,240.92 | 11,488,164.82 | 11,976,752.54 | 10,483,775.38 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-25 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |